.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Cerilliant
Medtronic
Mallinckrodt
Colorcon
Boehringer Ingelheim
Farmers Insurance
Fish and Richardson
Teva
Julphar

Generated: June 29, 2017

DrugPatentWatch Database Preview

LORELCO Drug Profile

« Back to Dashboard

Which patents cover Lorelco, and when can generic versions of Lorelco launch?

Lorelco is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in LORELCO is probucol. There are six drug master file entries for this compound. Additional details are available on the probucol profile page.

Summary for Tradename: LORELCO

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list51
Clinical Trials: see list4
Patent Applications: see list5,196
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LORELCO at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
LORELCO
probucol
TABLET;ORAL017535-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Sanofi Aventis Us
LORELCO
probucol
TABLET;ORAL017535-002Jul 6, 1988DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: LORELCO

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us
LORELCO
probucol
TABLET;ORAL017535-001Approved Prior to Jan 1, 19823,576,883► Subscribe
Sanofi Aventis Us
LORELCO
probucol
TABLET;ORAL017535-002Jul 6, 19883,862,332► Subscribe
Sanofi Aventis Us
LORELCO
probucol
TABLET;ORAL017535-001Approved Prior to Jan 1, 19823,862,332► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Express Scripts
Harvard Business School
Dow
Mallinckrodt
Novartis
Cantor Fitzgerald
Farmers Insurance
Argus Health
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot